ALLO-GLUE Trademark
Trademark Overview
On Tuesday, December 13, 2022, a trademark application was filed for ALLO-GLUE with the United States Patent and Trademark Office. The USPTO has given the ALLO-GLUE trademark a serial number of 97716240. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, June 11, 2024. This trademark is owned by Orionis Biosciences Inc.. The ALLO-GLUE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorders; Biochemical preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
Diagnostic and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology and pharmaceutical research and development; consulting services in the field of laboratory testing for scientific purposes in the field of pharmaceuticals and biotechnology; consulting services in the field of research and development of new products relating to diagnosis of diseases; consulting services in the field of pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism
General Information
| Serial Number | 97716240 |
| Word Mark | ALLO-GLUE |
| Filing Date | Tuesday, December 13, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, June 11, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 31, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorders; Biochemical preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases |
| Pseudo Mark | ALLOW GLUE |
| Goods and Services | Diagnostic and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases |
| Goods and Services | Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology and pharmaceutical research and development; consulting services in the field of laboratory testing for scientific purposes in the field of pharmaceuticals and biotechnology; consulting services in the field of research and development of new products relating to diagnosis of diseases; consulting services in the field of pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 10, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 10, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Orionis Biosciences Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
| Party Name | Orionis Biosciences Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02451 |
Trademark Events
| Event Date | Event Description |
| Friday, December 16, 2022 | NEW APPLICATION ENTERED |
| Tuesday, January 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, September 16, 2023 | ASSIGNED TO EXAMINER |
| Friday, September 22, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, September 22, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, September 22, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, September 22, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, September 22, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 11, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 31, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 31, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 26, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 11, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 11, 2024 | SOU EXTENSION 1 FILED |
| Tuesday, June 11, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, December 23, 2024 | SOU TEAS EXTENSION RECEIVED |
